Compare · MO vs XXII
MO vs XXII
Side-by-side comparison of Altria Group Inc. (MO) and 22nd Century Group Inc. (XXII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MO and XXII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- MO is the larger of the two at $122.11B, about 367.8x XXII ($332.0M).
- Both names hit the wire about 3 times in the past 4 weeks.
- MO has more recent analyst coverage (21 ratings vs 4 for XXII).
- Company
- Altria Group Inc.
- 22nd Century Group Inc.
- Price
- -
- -
- Market cap
- $122.11B
- $332.0M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- AMEX
- IPO
- News (4w)
- 3
- 3
- Recent ratings
- 21
- 4
Altria Group Inc.
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
22nd Century Group Inc.
22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Latest MO
- SEC Form 4 filed by Altria Group Inc.
- Altria to Host Webcast of 2026 Third-Quarter and Nine-Months Results
- SEC Form 8-K filed by Altria Group Inc.
- Director Mcquade Kathryn B. bought $101,430 worth of shares (1,500 units at $67.62), increasing direct ownership by 1% to 114,929 units (SEC Form 4)
- New insider Presley Steven W. claimed ownership of 1,081 shares (SEC Form 3)
- Altria Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Altria Announces Election of Steve Presley to Altria’s Board of Directors
- Altria Increases Quarterly Dividend to $1.11 Per Share
- Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
- Philip Morris International Announces Contract Manufacturing Collaboration with Altria
Latest XXII
- 22nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161%
- 22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
- 22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule
- 22nd Century Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- 22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter
- 22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026
- SEC Form S-8 filed by 22nd Century Group Inc.
- SEC Form 10-Q filed by 22nd Century Group Inc.
- 22nd Century Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 22nd Century Group Reports Second Quarter 2026 Financial Results